Ergoteles LLC Becton Dickinson & CO Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $1.66 Million - $1.95 Million	-7,589 Reduced 71.11%	3,083 $784,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $449,217 - $2.33 Million	8,803 Added 471.0%	10,672 $2.38 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $2.32 Million - $2.73 Million	-9,897 Reduced 84.12%	1,869 $461,000
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $2.87 Million - $3.18 Million	11,766 New	11,766 $3.13 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $1.67 Million - $1.83 Million	-7,273 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $1.69 Million - $1.87 Million	7,273 New	7,273 $1.79 Million
Q1 2021 May 12, 2021	SELL	$232.09 - $256.88 $732,476 - $810,713	-3,156 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$221.92 - $245.94 $2.32 Million - $2.57 Million	-10,444 Reduced 76.79%	3,156 $790,000
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $2.93 Million - $3.76 Million	13,600 New	13,600 $3.16 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.